| 1 |
Couvidou A, Rojas-Jiménez G, Dupuis A, Maître B. Anti-HLA Class I alloantibodies in platelet transfusion refractoriness: From mechanisms and determinants to therapeutic prospects. Front Immunol 2023;14:1125367. [PMID: 36845153 DOI: 10.3389/fimmu.2023.1125367] [Reference Citation Analysis]
|
| 2 |
Ding JN, Feng TT, Sun W, Cai XY, Zhang Y, Zhao WF. Recombinant human thrombopoietin treatment in patients with chronic liver disease-related thrombocytopenia undergoing invasive procedures: A retrospective study. World J Gastrointest Surg 2022; 14(11): 1260-1271 [DOI: 10.4240/wjgs.v14.i11.1260] [Reference Citation Analysis]
|
| 3 |
Gelbenegger G, Jilma B. Clinical pharmacology of antiplatelet drugs. Expert Rev Clin Pharmacol 2022. [PMID: 36065676 DOI: 10.1080/17512433.2022.2121702] [Reference Citation Analysis]
|
| 4 |
Wu S, Chen Q, Pan J, Zhou A. Platelet transfusion and mortality in patients with sepsis‐induced thrombocytopenia: A propensity score matching analysis. Vox Sanguinis. [DOI: 10.1111/vox.13335] [Reference Citation Analysis]
|
| 5 |
Lu J, Jamieson BD, Hui AM. Avatrombopag ethnic sensitivity analysis in chronic liver disease and thrombocytopenia patients: individual-level pooled analysis. Therap Adv Gastroenterol 2022;15:17562848221105976. [PMID: 35795378 DOI: 10.1177/17562848221105976] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 6 |
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis. J Hepatol 2022;76:1151-84. [PMID: 35300861 DOI: 10.1016/j.jhep.2021.09.003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 37.0] [Reference Citation Analysis]
|
| 7 |
Eguchi Y, Takahashi H, Mappa S, Santagostino E. Phase 2 study of avatrombopag in Japanese patients with chronic liver disease and thrombocytopenia. Hepatol Res 2022;52:371-80. [PMID: 35134259 DOI: 10.1111/hepr.13755] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Schilling M, Rickmann L, Hutschenreuter G, Spreckelsen C. Reduction of Platelet Outdating and Shortage by Forecasting Demand With Statistical Learning and Deep Neural Networks: Modeling Study. JMIR Med Inform 2022;10:e29978. [PMID: 35103612 DOI: 10.2196/29978] [Reference Citation Analysis]
|
| 9 |
Ansari D, Guntin JA, Shah P, Patil SN, Patel S, Kumar M, Heron D, Mehta AI. Thrombocytopenia as an Independent Prognostic Indicator Following Extradural Spinal Tumor Resection. World Neurosurg 2022:S1878-8750(21)01954-9. [PMID: 34990841 DOI: 10.1016/j.wneu.2021.12.109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Akça B. Platelet-Rich Concentrates. Transfusion Practice in Clinical Neurosciences 2022. [DOI: 10.1007/978-981-19-0954-2_28] [Reference Citation Analysis]
|
| 11 |
Colomina MJ, Contreras L, Pariente L. Blood transfusion triggers. Essentials of Evidence-Based Practice of Neuroanesthesia and Neurocritical Care 2022. [DOI: 10.1016/b978-0-12-821776-4.00017-2] [Reference Citation Analysis]
|
| 12 |
Chowdhry M, Agrawal S, Prakash B, Thakur UK, Mishra M. Platelet additive solution suspended apheresis platelets in a tertiary care hospital: A step toward universal single donor platelets. Asian J Transfus Sci 2022;16:238-44. [PMID: 36687537 DOI: 10.4103/ajts.ajts_145_21] [Reference Citation Analysis]
|
| 13 |
Aguilar G, Ortiz N, Gonzales D, Loyola S, Paredes JA. High titers of anti-A1 and anti-B antibodies among Peruvian group O platelet donors. Transfus Apher Sci 2021;:103341. [PMID: 34916156 DOI: 10.1016/j.transci.2021.103341] [Reference Citation Analysis]
|
| 14 |
Neuenfeldt FS, Weigand MA, Fischer D. Coagulopathies in Intensive Care Medicine: Balancing Act between Thrombosis and Bleeding. J Clin Med 2021;10:5369. [PMID: 34830667 DOI: 10.3390/jcm10225369] [Reference Citation Analysis]
|
| 15 |
Napeñas JJ, Patton LL. Bleeding and Clotting Disorders. Burket's Oral Medicine 2021. [DOI: 10.1002/9781119597797.ch18] [Reference Citation Analysis]
|
| 16 |
Sano Y, Morimoto M, Kobayashi S, Ueno M, Fukushima T, Asama H, Kawano K, Nagashima S, Tanaka S, Ohkawa S, Maeda S. Repeated Lusutrombopag Treatment for Thrombocytopenia in Patients with Chronic Liver Disease. Digestion 2021;102:654-62. [PMID: 32841939 DOI: 10.1159/000509852] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Lee RH, Kasthuri RS, Bergmeier W. Platelet transfusion for patients with platelet dysfunction: effectiveness, mechanisms, and unanswered questions. Curr Opin Hematol 2020;27:378-85. [PMID: 32868672 DOI: 10.1097/MOH.0000000000000608] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Lim MY, Gilreath JA. Periprocedural use of avatrombopag for neurosurgical interventions: a strategy to avoid platelet utilization. Blood Adv 2020;4:4438-41. [PMID: 32936905 DOI: 10.1182/bloodadvances.2020003045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 19 |
Triulzi DJ. How well do platelets prevent bleeding? Hematology Am Soc Hematol Educ Program 2020;2020:518-22. [PMID: 33275687 DOI: 10.1182/hematology.2020000136] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 20 |
Schilling M, Rickmann L, Hutschenreuter G, Spreckelsen C. Reduction of Platelet Outdating and Shortage by Forecasting Demand With Statistical Learning and Deep Neural Networks: Modeling Study (Preprint).. [DOI: 10.2196/preprints.29978] [Reference Citation Analysis]
|
| 21 |
Mohammad Shehata I, Elhassan A, Alejandro Munoz D, Okereke B, Cornett EM, Varrassi G, Imani F, Kaye AD, Sehat-Kashani S, Urits I, Viswanath O. Intraoperative Hypotension Increased Risk in the Oncological Patient. Anesth Pain Med 2021;11:e112830. [PMID: 34221948 DOI: 10.5812/aapm.112830] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Mawardi H, Treister N, Felemban O, Alamoudi W, Algohary G, Alsultan A, Alshehri N, Tazi I, Shaheen M, Alsharani M, Alshemmari S, Arat M, Bekadja MA, Al-Khabori M, Okaily S, Ali N, Abujazar H, Jastaniah W, Hamidieh AA, Hashmi S, Aljurf M. Current practice of oral care for hematopoietic stem cell transplant patients: A survey of the Eastern Mediterranean Blood and Marrow transplantation group. Hematol Oncol Stem Cell Ther 2021:S1658-3876(21)00006-6. [PMID: 33631114 DOI: 10.1016/j.hemonc.2021.01.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 23 |
Miyauchi T, Saga I, Kojima A. Acute Subdural Hematoma Complicating Heparin-induced Thrombocytopenia: A Case Report. NMC Case Report Journal 2021;8:799-803. [DOI: 10.2176/nmccrj.cr.2021-0262] [Reference Citation Analysis]
|
| 24 |
Dieterich DT, Bernstein D, Flamm S, Pockros PJ, Reau N. Review article: a treatment algorithm for patients with chronic liver disease and severe thrombocytopenia undergoing elective medical procedures in the United States. Aliment Pharmacol Ther 2020;52:1311-22. [PMID: 32813292 DOI: 10.1111/apt.16044] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 25 |
Poordad F, Terrault NA, Alkhouri N, Tian W, Allen LF, Rabinovitz M. Avatrombopag, an Alternate Treatment Option to Reduce Platelet Transfusions in Patients with Thrombocytopenia and Chronic Liver Disease-Integrated Analyses of 2 Phase 3 Studies. Int J Hepatol 2020;2020:5421632. [PMID: 32047671 DOI: 10.1155/2020/5421632] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 26 |
Solves Alcaina P. Platelet Transfusion: And Update on Challenges and Outcomes. J Blood Med 2020;11:19-26. [PMID: 32158298 DOI: 10.2147/JBM.S234374] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
|
| 27 |
Ajmani PS. Storage of Blood. Immunohematology and Blood banking 2020. [DOI: 10.1007/978-981-15-8435-0_4] [Reference Citation Analysis]
|
| 28 |
Walter JM. Thrombocytopenia in the Intensive Care Unit. Evidence-Based Critical Care 2020. [DOI: 10.1007/978-3-030-26710-0_83] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 29 |
Zhou Z, Feng T, Xie Y, Huang P, Xie H, Tian R, Qian B, Wang R. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).BMC Infect Dis. 2019;19:780. [PMID: 31492102 DOI: 10.1186/s12879-019-4388-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 30 |
Xu X, Zhang Y, Yu X, Huang Y. Preoperative moderate thrombocytopenia is not associated with increased blood loss for low-risk cesarean section: a retrospective cohort study. BMC Pregnancy Childbirth 2019;19:269. [PMID: 31357932 DOI: 10.1186/s12884-019-2417-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 31 |
Długosz-Danecka M, Zdziarska J, Jurczak W. Avatrombopag for the treatment of immune thrombocytopenia. Expert Rev Clin Immunol 2019;15:327-39. [PMID: 30799645 DOI: 10.1080/1744666X.2019.1587294] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 32 |
Ddungu H, Krantz EM, Kajja I, Naluzze S, Nabbanja H, Nalubwama F, Phipps W, Orem J, Kiwanuka N, Wald A. How low can you go: What is the safe threshold for platelet transfusions in patients with hematologic malignancy in sub-Saharan Africa. PLoS One 2019;14:e0211648. [PMID: 30726290 DOI: 10.1371/journal.pone.0211648] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 33 |
Kumar M, Cucchiara B. Hematologic Interventions for Acute Central Nervous System Disease. Consultative Hemostasis and Thrombosis 2019. [DOI: 10.1016/b978-0-323-46202-0.00038-8] [Reference Citation Analysis]
|
| 34 |
Tanaka KA, Bolliger D. Transfusion and Coagulation Therapy. Pharmacology and Physiology for Anesthesia 2019. [DOI: 10.1016/b978-0-323-48110-6.00044-2] [Reference Citation Analysis]
|
| 35 |
Leary B, Cuccovia B, Nixon C. Nursing Considerations. Critical Care of the Pediatric Immunocompromised Hematology/Oncology Patient 2019. [DOI: 10.1007/978-3-030-01322-6_19] [Reference Citation Analysis]
|
| 36 |
Karlström C, Linjama T, Edgren G, Lauronen J, Wikman A, Höglund P. HLA-selected platelets for platelet refractory patients with HLA antibodies: a single-center experience: HLA-MATCHING IN PLATELET REFRACTORINESS. Transfusion 2019;59:945-52. [DOI: 10.1111/trf.15108] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 37 |
Palandri F, Catani L, Auteri G, Bartoletti D, Fatica S, Fusco A, Bacchi Reggiani ML, Cavo M, Vianelli N. Understanding how older age drives decision-making and outcome in Immune Thrombocytopenia. A single centre study on 465 adult patients. Br J Haematol 2019;184:424-30. [DOI: 10.1111/bjh.15668] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 38 |
Jo CH, Lee SY, Yoon KS, Oh S, Shin S. Allogenic Pure Platelet-Rich Plasma Therapy for Rotator Cuff Disease: A Bench and Bed Study. Am J Sports Med 2018;46:3142-54. [PMID: 30311796 DOI: 10.1177/0363546518800268] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 5.8] [Reference Citation Analysis]
|
| 39 |
Estcourt LJ, Malouf R, Doree C, Trivella M, Hopewell S, Birchall J. Prophylactic platelet transfusions prior to surgery for people with a low platelet count. Cochrane Database Syst Rev 2018;9:CD012779. [PMID: 30221749 DOI: 10.1002/14651858.CD012779.pub2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 40 |
Terrault N, Chen YC, Izumi N, Kayali Z, Mitrut P, Tak WY, Allen LF, Hassanein T. Avatrombopag Before Procedures Reduces Need for Platelet Transfusion in Patients With Chronic Liver Disease and Thrombocytopenia. Gastroenterology 2018;155:705-18. [PMID: 29778606 DOI: 10.1053/j.gastro.2018.05.025] [Cited by in Crossref: 124] [Cited by in F6Publishing: 127] [Article Influence: 24.8] [Reference Citation Analysis]
|
| 41 |
Estcourt LJ, Crighton GL, Wood EM, Stanworth S, Trivella M, Doree C, Tinmouth A, Murphy MF. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010981. [PMID: 25722649 DOI: 10.1002/14651858.CD010981] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 42 |
Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Murphy MF, Tinmouth A. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010983. [PMID: 25722651 DOI: 10.1002/14651858.CD010983] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 43 |
Estcourt LJ, Malouf R, Hopewell S, Doree C, Van Veen J. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database Syst Rev 2018;4:CD011980. [PMID: 29709077 DOI: 10.1002/14651858.CD011980.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 44 |
Bao HX, Du J, Chen BY, Wang Y. The role of thromboelastography in predicting hemorrhage risk in patients with leukemia. Medicine (Baltimore) 2018;97:e0137. [PMID: 29595638 DOI: 10.1097/MD.0000000000010137] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 45 |
Braidy HF. Review of Thrombocytopenia and Perioperative Management in Dentistry. Hemostasis in Dentistry 2018. [DOI: 10.1007/978-3-319-71240-6_5] [Reference Citation Analysis]
|
| 46 |
Sam JE, Gee TS, Wahab NA. Fatal Intracranial Hemorrhage in a Patient with Severe Dengue Fever. Asian J Neurosurg 2018;13:56-8. [PMID: 29492121 DOI: 10.4103/1793-5482.185056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 47 |
Budak-alpdogan T, Levine J, Dellinger P. Hematologic Issues in Sepsis. Hematologic Challenges in the Critically Ill 2018. [DOI: 10.1007/978-3-319-93572-0_7] [Reference Citation Analysis]
|
| 48 |
Dutcher JP. Platelet and Granulocyte Transfusion. Neoplastic Diseases of the Blood 2018. [DOI: 10.1007/978-3-319-64263-5_54] [Reference Citation Analysis]
|
| 49 |
Robba C. Intracranial Pressure Monitoring. Neuromonitoring Techniques 2018. [DOI: 10.1016/b978-0-12-809915-5.00001-2] [Reference Citation Analysis]
|
| 50 |
Etchells M, Spradbrow J, Cohen R, Lin Y, Armali C, Lieberman L, Cserti-Gazdewich C, Pendergrast J, Callum J. Audit of appropriate use of platelet transfusions: validation of adjudication criteria. Vox Sang 2018;113:40-50. [PMID: 29052231 DOI: 10.1111/vox.12550] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 51 |
Li D, Glor T, Jones GA. Thrombocytopenia and Neurosurgery: A Literature Review. World Neurosurgery 2017;106:277-80. [DOI: 10.1016/j.wneu.2017.06.097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 52 |
Levy JH, Rossaint R, Zacharowski K, Spahn DR. What is the evidence for platelet transfusion in perioperative settings? Vox Sang 2017;112:704-12. [DOI: 10.1111/vox.12576] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
|
| 53 |
Estcourt LJ, Malouf R, Doree C, Trivella M, Hopewell S, Birchall J. Prophylactic platelet transfusions prior to surgery for people with a low platelet count. Cochrane Database Syst Rev 2017;2017:CD012779. [PMID: 29151812 DOI: 10.1002/14651858.CD012779] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 54 |
Peck-Radosavljevic M. Thrombocytopenia in chronic liver disease. Liver Int 2017;37:778-93. [PMID: 27860293 DOI: 10.1111/liv.13317] [Cited by in Crossref: 123] [Cited by in F6Publishing: 125] [Article Influence: 20.5] [Reference Citation Analysis]
|
| 55 |
Gurevich-Shapiro A, Tzadok S, Rosenberg A, Inbal A, Bar-Natan M, Wolach O, Raanani P. Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience. Acta Haematol 2017;137:183-90. [PMID: 28419992 DOI: 10.1159/000465510] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 56 |
Kreuger AL, Caram-deelder C, Jacobse J, Kerkhoffs J, van der Bom JG, Middelburg RA. Effect of storage time of platelet products on clinical outcomes after transfusion: a systematic review and meta-analyses. Vox Sang 2017;112:291-300. [DOI: 10.1111/vox.12494] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 57 |
De Sancho MT, Rand JH. Coagulopathic Complications of Cancer Patients. Holland-Frei Cancer Medicine 2017. [DOI: 10.1002/9781119000822.hfcm131] [Reference Citation Analysis]
|
| 58 |
Vanderwerf JD, Kumar MA. Management of neurologic complications of coagulopathies. Handb Clin Neurol 2017;141:743-64. [PMID: 28190445 DOI: 10.1016/B978-0-444-63599-0.00040-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 59 |
Marino PL. Thrombozyten und Plasma. Das ICU-Buch 2017. [DOI: 10.1016/b978-3-437-23162-9.00019-6] [Reference Citation Analysis]
|
| 60 |
Stewart E, Ng VL. Test Utilization: The Essential Role of the Clinical Consultant. Utilization Management in the Clinical Laboratory and Other Ancillary Services 2017. [DOI: 10.1007/978-3-319-34199-6_22] [Reference Citation Analysis]
|
| 61 |
Malone DG, Freedman BA. Blood Loss Management. Benzel's Spine Surgery, 2-Volume Set 2017. [DOI: 10.1016/b978-0-323-40030-5.00198-2] [Reference Citation Analysis]
|
| 62 |
Petros S. RETRACTED ARTICLE: Therapie mit Blutprodukten. Notfall Rettungsmed 2016;19:685-695. [DOI: 10.1007/s10049-016-0242-x] [Reference Citation Analysis]
|
| 63 |
Hunt BJ. Intensive and Critical Care. Practical Hemostasis and Thrombosis 2016. [DOI: 10.1002/9781118344729.ch28] [Reference Citation Analysis]
|
| 64 |
Greinacher A, Selleng S. How I evaluate and treat thrombocytopenia in the intensive care unit patient. Blood 2016;128:3032-42. [PMID: 28034871 DOI: 10.1182/blood-2016-09-693655] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 6.1] [Reference Citation Analysis]
|
| 65 |
Desborough M, Hadjinicolaou AV, Chaimani A, Trivella M, Vyas P, Doree C, Hopewell S, Stanworth SJ, Estcourt LJ. Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review. Cochrane Database Syst Rev 2016;10:CD012055. [PMID: 27797129 DOI: 10.1002/14651858.CD012055.pub2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 66 |
Berger K, Schopohl D, Wittmann G, Schramm W, Ostermann H, Rieger C. Blood Product Supply in Germany: The Impact of Apheresis and Pooled Platelet Concentrates. Transfus Med Hemother 2016;43:389-94. [PMID: 27994524 DOI: 10.1159/000445442] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 67 |
Morotti A, Goldstein JN. Diagnosis and Management of Acute Intracerebral Hemorrhage. Emerg Med Clin North Am 2016;34:883-99. [PMID: 27741993 DOI: 10.1016/j.emc.2016.06.010] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 7.7] [Reference Citation Analysis]
|
| 68 |
Desborough M, Estcourt LJ, Doree C, Trivella M, Hopewell S, Stanworth SJ, Murphy MF. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2016;:CD010982. [PMID: 27548292 DOI: 10.1002/14651858.CD010982.pub2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 69 |
Campagna M. Chemotherapy Complications. Hospital Medicine Clinics 2016;5:400-12. [DOI: 10.1016/j.ehmc.2016.02.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 70 |
Sam JE, Gee TS, Nasser AW. Deadly intracranial bleed in patients with dengue fever: A series of nine patients and review of literature. J Neurosci Rural Pract 2016;7:423-34. [PMID: 27365962 DOI: 10.4103/0976-3147.182777] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 71 |
Buck R, Wachsberg K. Blood Transfusions for Hospitalized Patients with Cancer. Hospital Medicine Clinics 2016;5:356-367. [DOI: 10.1016/j.ehmc.2016.02.006] [Reference Citation Analysis]
|
| 72 |
Palandri F, Polverelli N, Sollazzo D, Romano M, Catani L, Cavo M, Vianelli N. Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years. Am J Hematol 2016;91:E267-72. [PMID: 26799593 DOI: 10.1002/ajh.24310] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
|
| 73 |
Mannuß S, Schuff-Werner P, Dreißiger K, Kohlschein P. Magnesium Sulfate as an Alternative In Vitro Anticoagulant for the Measurement of Platelet Parameters? Am J Clin Pathol 2016;145:806-14. [PMID: 27282617 DOI: 10.1093/ajcp/aqw066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 74 |
Estcourt LJ, Ingram C, Doree C, Trivella M, Stanworth SJ. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database Syst Rev 2016;:CD011980. [PMID: 27218879 DOI: 10.1002/14651858.CD011980.pub2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 75 |
Smethurst PA. Aging of platelets stored for transfusion. Platelets 2016;27:526-34. [PMID: 27135140 DOI: 10.3109/09537104.2016.1171303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 76 |
Xin X, Liu Z, Jian C, Tian M, Fang J, Sun H, Zhou J, Li D. The role of thromboelastography in predicting bleeding risk and guiding the administration of platelet transfusions in hematological patients: a cohort study. Ann Hematol 2016;95:1163-8. [DOI: 10.1007/s00277-016-2658-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 77 |
Tamamyan G, Danielyan S, Lambert MP. Chemotherapy induced thrombocytopenia in pediatric oncology. Critical Reviews in Oncology/Hematology 2016;99:299-307. [DOI: 10.1016/j.critrevonc.2016.01.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.9] [Reference Citation Analysis]
|
| 78 |
Petros S. [Therapy with blood products]. Med Klin Intensivmed Notfmed 2016;111:241-9; quiz 250-1. [PMID: 26825633 DOI: 10.1007/s00063-015-0138-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 79 |
Desborough M, Estcourt LJ, Chaimani A, Doree C, Hopewell S, Trivella M, Hadjinicolaou AV, Vyas P, Stanworth SJ. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review. Cochrane Database Syst Rev 2016;2016:CD012055. [PMID: 27069420 DOI: 10.1002/14651858.CD012055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 80 |
Vaglio S, Prisco D, Biancofiore G, Rafanelli D, Antonioli P, Lisanti M, Andreani L, Basso L, Velati C, Grazzini G, Liumbruno GM. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood Transfus 2016;14:23-65. [PMID: 26710356 DOI: 10.2450/2015.0172-15] [Cited by in F6Publishing: 38] [Reference Citation Analysis]
|
| 81 |
Estcourt LJ, Ingram C, Doree C, Hopewell S, Trivella M, Stanworth SJ. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia. Cochrane Database Syst Rev 2015;2015. [PMID: 27057148 DOI: 10.1002/14651858.CD011980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 82 |
Zhu C, Gao Y, Li Z, Li Q, Gao Z, Liao Y, Deng Z. A Systematic Review and Meta-Analysis of the Clinical Appropriateness of Blood Transfusion in China. Medicine (Baltimore) 2015;94:e2164. [PMID: 26683925 DOI: 10.1097/MD.0000000000002164] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 83 |
Thai A, Leung JW. Endoscopic Diagnosis and Treatment of Nonvariceal Upper Gastrointestinal Hemorrhage. Yamada' s Textbook of Gastroenterology 2015. [DOI: 10.1002/9781118512074.ch139] [Reference Citation Analysis]
|
| 84 |
El Haddad D, Iliescu C, Yusuf SW, William WN Jr, Khair TH, Song J, Mouhayar EN. Outcomes of Cancer Patients Undergoing Percutaneous Pericardiocentesis for Pericardial Effusion. J Am Coll Cardiol 2015;66:1119-28. [PMID: 26337990 DOI: 10.1016/j.jacc.2015.06.1332] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 85 |
Estcourt LJ, Stanworth SJ, Doree C, Hopewell S, Trivella M, Murphy MF. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015;:CD010983. [PMID: 26576687 DOI: 10.1002/14651858.CD010983.pub2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 86 |
Estcourt LJ, Stanworth S, Doree C, Trivella M, Hopewell S, Blanco P, Murphy MF. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2015;:CD010984. [PMID: 26505729 DOI: 10.1002/14651858.CD010984.pub2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 87 |
Valsami S, Dimitroulis D, Gialeraki A, Chimonidou M, Politou M. Current trends in platelet transfusions practice: The role of ABO-RhD and human leukocyte antigen incompatibility. Asian J Transfus Sci 2015;9:117-23. [PMID: 26420927 DOI: 10.4103/0973-6247.162684] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
|
| 88 |
Akay OM, Goren Sahin D, Andic N, Gunduz E, Karagulle M, Colak E, Gulbas Z. The utility of thromboelastometry in prophylactic platelet transfusion for hematological malignancies. Transfusion and Apheresis Science 2015;53:64-8. [DOI: 10.1016/j.transci.2015.03.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 89 |
Lehner B, Eichelberger B, Jungbauer C, Panzer S. The Blood Group A Genotype Determines the Level of Expression of the Blood Group A on Platelets But Not the Anti-B Isotiter. Transfus Med Hemother 2015;42:366-71. [PMID: 26733767 DOI: 10.1159/000432414] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 90 |
Lee C, Ayob Y. Approach to managing platelet refractory patients. VOXS 2015;10:89-94. [DOI: 10.1111/voxs.12139] [Reference Citation Analysis]
|
| 91 |
Peña JR, Saidman SL. Anti-HLA antibody testing in hematology patients. Am J Hematol 2015;90:361-4. [PMID: 25580568 DOI: 10.1002/ajh.23935] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 92 |
Riviere E, Saint-léger M, James C, Delmas Y, Clouzeau B, Bui N, Vital A, Coppo P, Gruson D, Boyer A. Platelet transfusion and catheter insertion for plasma exchange in patients with thrombotic thrombocytopenic purpura and a low platelet count: PLT Transfusion for Catheter Insertion in TTP. Transfusion 2015;55:1798-802. [DOI: 10.1111/trf.13041] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.4] [Reference Citation Analysis]
|
| 93 |
Kloskowski T, Nowacki M, Pokrywczyńska M, Drewa T. Urine--a waste or the future of regenerative medicine? Med Hypotheses 2015;84:344-9. [PMID: 25649852 DOI: 10.1016/j.mehy.2015.01.019] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 94 |
Cotton BA, Mcelroy LA. Universal Donor. Encyclopedia of Trauma Care 2015. [DOI: 10.1007/978-3-642-29613-0_95] [Reference Citation Analysis]
|
| 95 |
Dua A, Holcomb JB. Platelet Transfusion in Trauma. Encyclopedia of Trauma Care 2015. [DOI: 10.1007/978-3-642-29613-0_25] [Reference Citation Analysis]
|
| 96 |
Deloughery TG. Transfusion Therapy and Massive Transfusions. Hemostasis and Thrombosis 2015. [DOI: 10.1007/978-3-319-09312-3_14] [Reference Citation Analysis]
|
| 97 |
Ziegler B, Solomon C, Cadamuro J, Jones N. Thromboelastometric Monitoring of the Hemostatic Effect of Platelet Concentrates Transfusion in Thrombocytopenic Children Undergoing Chemotherapy. Clin Appl Thromb Hemost 2015;21:558-64. [PMID: 25525046 DOI: 10.1177/1076029614564862] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 98 |
Brachemi S, Bollée G. Renal biopsy practice: What is the gold standard? World J Nephrol 2014; 3(4): 287-294 [PMID: 25374824 DOI: 10.5527/wjn.v3.i4.287] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 99 |
Podda GM, Ricci S. Platelet transfusion strategy for hematologic cancers. Intern Emerg Med 2015;10:81-2. [PMID: 25358897 DOI: 10.1007/s11739-014-1148-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 100 |
Philip J, Biswas AK, Chatterjee T, Mallhi RS. Comparative Analysis of Various Aspects of Plateletpheresis on the Fenwal Amicus and Fresenius COM.TEC Cell Separator Instruments. Lab Med 2014;45:315-23. [PMID: 25316663 DOI: 10.1309/LM491RNLMWLFHIMS] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 101 |
Geraldo RB, Sathler PC, Lourenço AL, Saito MS, Cabral LM, Rampelotto PH, Castro HC. Platelets: still a therapeutical target for haemostatic disorders. Int J Mol Sci 2014;15:17901-19. [PMID: 25295482 DOI: 10.3390/ijms151017901] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 102 |
Hagisawa K, Nishikawa K, Yanagawa R, Kinoshita M, Doi M, Suzuki H, Iwaya K, Saitoh D, Seki S, Takeoka S, Handa M, Nishida Y. Treatment with fibrinogen γ-chain peptide-coated, adenosine 5'-diphosphate-encapsulated liposomes as an infusible hemostatic agent against active liver bleeding in rabbits with acute thrombocytopenia. Transfusion 2015;55:314-25. [PMID: 25145766 DOI: 10.1111/trf.12829] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
|
| 103 |
Desborough MJ, Jairath V. Is treatment of moderate thrombocytopenia indicated for patients with HCV infection and cirrhosis? Gastroenterology 2014;147:254. [PMID: 24877869 DOI: 10.1053/j.gastro.2014.02.058] [Reference Citation Analysis]
|
| 104 |
Samiev D, Bhatt VR, Armitage JD, Maness LJ, Akhtari M. A primary care approach to myelodysplastic syndromes. Korean J Fam Med 2014;35:111-8. [PMID: 24921029 DOI: 10.4082/kjfm.2014.35.3.111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 105 |
Rioux-Massé B, Cohn C, Lindgren B, Pulkrabek S, McCullough J. Utilization of cross-matched or HLA-matched platelets for patients refractory to platelet transfusion. Transfusion 2014;54:3080-7. [PMID: 24916382 DOI: 10.1111/trf.12739] [Cited by in Crossref: 30] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 106 |
Solves P, Moscardo F, Lancharro A, Cano I, Carpio N, Sanz MÁ. A retrospective audit of platelet transfusion in a hematology service of a tertiary-care hospital: Effectiveness of training to improve compliance with standards. Transfusion and Apheresis Science 2014;50:228-9. [DOI: 10.1016/j.transci.2013.11.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 107 |
Estcourt LJ, Gregg R, Stanworth S, Doree C, Trivella M, Murphy MF, Tinmouth A. Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with haematological disorders after chemotherapy or stem cell transplantation. Cochrane Database Syst Rev 2014:CD010982. [PMID: 25722650 DOI: 10.1002/14651858.CD010982] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 108 |
McIntyre L, Tinmouth AT, Fergusson DA. Blood component transfusion in critically ill patients. Curr Opin Crit Care. 2013;19:326-333. [PMID: 23817027 DOI: 10.1097/mcc.0b013e3283632e56] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
|
| 109 |
Saposnik B, Binard S, Fenneteau O, Nurden A, Nurden P, Hurtaud-Roux MF, Schlegel N; French MYH9 networka. Mutation spectrum and genotype-phenotype correlations in a large French cohort of MYH9-Related Disorders. Mol Genet Genomic Med 2014;2:297-312. [PMID: 25077172 DOI: 10.1002/mgg3.68] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 110 |
Collins RA, Triulzi DJ, Waters JH, Reddy V, Yazer MH. Evaluation of real-time clinical decision support systems for platelet and cryoprecipitate orders. Am J Clin Pathol 2014;141:78-84. [PMID: 24343740 DOI: 10.1309/AJCP1OSRTPUJE9XS] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 111 |
Isbister JP. Blood transfusion. Oh's Intensive Care Manual 2014. [DOI: 10.1016/b978-0-7020-4762-6.00095-3] [Reference Citation Analysis]
|
| 112 |
Torres MEU, Rodríguez JNR, Ramos JLS, Gómez FA. Transfusion in Palliative Cancer Patients: A Review of the Literature. Journal of Palliative Medicine 2014;17:88-104. [DOI: 10.1089/jpm.2013.0387] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 3.4] [Reference Citation Analysis]
|
| 113 |
Szczepiorkowski ZM, Dunbar NM. Transfusion guidelines: when to transfuse. Hematology 2013;2013:638-44. [DOI: 10.1182/asheducation-2013.1.638] [Cited by in Crossref: 57] [Cited by in F6Publishing: 67] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 114 |
Fayed NA, Abdallah AR, Khalil MK, Marwan IK. Therapeutic rather than prophylactic platelet transfusion policy for severe thrombocytopenia during liver transplantation. Platelets 2014;25:576-86. [PMID: 24246132 DOI: 10.3109/09537104.2013.849335] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 115 |
Almomen A, Aleem A, Alshaik M, Hasanato R. Intrapulmonary rFVIIa for life threatening pulmonary hemorrhage in a case of relapsing acute lymphoblastic leukemia and platelet refractoriness. Platelets 2014;25:452-4. [PMID: 24102447 DOI: 10.3109/09537104.2013.835797] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 116 |
Sawant RB, Marathe AN. Pooled platelet product using the Acrodose plus system: evaluation of feasibility, safety and efficacy. Transfus Apher Sci 2013;49:535-8. [PMID: 24080148 DOI: 10.1016/j.transci.2013.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 117 |
Chakrabarti P, Chaudhuri U, Raut LS, Nath UK. Comments on chronic subdural hematoma in a child with acute myeloid leukemia after leukocytosis. Indian Journal of Critical Care Medicine 2013;17:324-325. [DOI: 10.4103/0972-5229.120333] [Reference Citation Analysis]
|
| 118 |
Tomoyose T, Ohama M, Yamanoha A, Masuzaki H, Okudaira T, Tokumine J. Real-time ultrasound-guided central venous catheterization reduces the need for prophylactic platelet transfusion in thrombocytopenic patients with hematological malignancy. Transfus Apher Sci 2013;49:367-9. [PMID: 23083962 DOI: 10.1016/j.transci.2012.09.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 119 |
Song JG, Jeong SM, Jun IG, Lee HM, Hwang GS. Five-minute parameter of thromboelastometry is sufficient to detect thrombocytopenia and hypofibrinogenaemia in patients undergoing liver transplantation. Br J Anaesth. 2014;112:290-297. [PMID: 24065728 DOI: 10.1093/bja/aet325] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 7.2] [Reference Citation Analysis]
|
| 120 |
Ferrer-Marin F, Stanworth S, Josephson C, Sola-Visner M. Distinct differences in platelet production and function between neonates and adults: implications for platelet transfusion practice. Transfusion 2013;53:2814-21; quiz 2813. [PMID: 23889476 DOI: 10.1111/trf.12343] [Cited by in Crossref: 46] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
|
| 121 |
Hernandez E, Talamanates E, Kirimis E. An Approach to Thrombocytopenia in the Hospital. Hospital Medicine Clinics 2013;2:e422-e436. [DOI: 10.1016/j.ehmc.2013.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 122 |
Xiao W, Tormey CA, Capetillo A, Maitta RW. Allergic transfusion reactions to platelets are more commonly associated with prepooled than apheresis components. Vox Sang 2013;105:334-40. [DOI: 10.1111/vox.12063] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 123 |
Thiagarajan P, Afshar-kharghan V. Platelet Transfusion Therapy. Hematology/Oncology Clinics of North America 2013;27:629-43. [DOI: 10.1016/j.hoc.2013.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.9] [Reference Citation Analysis]
|
| 124 |
Danish FI, Yasmin S. The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia. Hepat Med 2013;5:17-30. [PMID: 24696622 DOI: 10.2147/HMER.S27100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 125 |
Oberoi S, Suthar R, Bansal D, Marwaha RK. Febrile neutropenia: outline of management. Indian J Pediatr 2013;80:138-43. [PMID: 23180404 DOI: 10.1007/s12098-012-0901-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 126 |
Kumar M, Cucchiara B. Hematologic Interventions for Acute Central Nervous System Disease. Consultative Hemostasis and Thrombosis. Elsevier; 2013. pp. 737-53. [DOI: 10.1016/b978-1-4557-2296-9.00042-7] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 127 |
Dutcher JP. Platelet and Granulocyte Transfusion. Neoplastic Diseases of the Blood 2013. [DOI: 10.1007/978-1-4614-3764-2_56] [Reference Citation Analysis]
|
| 128 |
Tanaka K. Transfusion and Coagulation Therapy. Pharmacology and Physiology for Anesthesia 2013. [DOI: 10.1016/b978-1-4377-1679-5.00036-3] [Reference Citation Analysis]
|
| 129 |
Afshar M, Netzer G. Update in critical care for the nephrologist: transfusion in nonhemorrhaging critically ill patients. Adv Chronic Kidney Dis 2013;20:30-8. [PMID: 23265594 DOI: 10.1053/j.ackd.2012.10.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 130 |
Vianelli N, Palandri F, Polverelli N, Stasi R, Joelsson J, Johansson E, Ruggeri M, Zaja F, Cantoni S, Catucci AE, Candoni A, Morra E, Björkholm M, Baccarani M, Rodeghiero F. Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years. Haematologica 2013;98:875-80. [PMID: 23144195 DOI: 10.3324/haematol.2012.075648] [Cited by in Crossref: 74] [Cited by in F6Publishing: 83] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 131 |
Eldin KW, Teruya J. Blood Components for Hemostasis. Lab Med 2012;43:237-44. [DOI: 10.1309/lmnu4k1zern1cdkv] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 132 |
Estcourt LJ, Birchall J, Lowe D, Grant-Casey J, Rowley M, Murphy MF. Platelet transfusions in haematology patients: are we using them appropriately? Vox Sang 2012;103:284-93. [PMID: 22775395 DOI: 10.1111/j.1423-0410.2012.01627.x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 69] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 133 |
Razzaghi A, Barkun AN. Platelet transfusion threshold in patients with upper gastrointestinal bleeding: a systematic review. J Clin Gastroenterol 2012;46:482-6. [PMID: 22688143 DOI: 10.1097/MCG.0b013e31823d33e3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 43] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 134 |
Luban NL, McBride E, Ford JC, Gupta S. Transfusion medicine problems and solutions for the pediatric hematologist/oncologist. Pediatr Blood Cancer 2012;58:1106-11. [PMID: 22238206 DOI: 10.1002/pbc.24077] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 135 |
Belen FB, Okur A, Kulali F, Egritas O, Kocak U, Kaya Z, Altuntas N, Yenicesu I. Platelet usage trends in a tertiary care hospital - Could it be less and less expensive? Transfus Apher Sci 2012;47:101-6. [PMID: 22592083 DOI: 10.1016/j.transci.2012.05.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 136 |
Estcourt L, Stanworth S, Doree C, Hopewell S, Murphy MF, Tinmouth A, Heddle N. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation. Cochrane Database Syst Rev 2012;:CD004269. [PMID: 22592695 DOI: 10.1002/14651858.CD004269.pub3] [Cited by in Crossref: 46] [Cited by in F6Publishing: 56] [Article Influence: 4.2] [Reference Citation Analysis]
|
| 137 |
Buhrkuhl DC, Karlsson MKP, Carter JM. An audit of platelet transfusion within the Wellington Cancer Centre: Audit of platelet transfusion in a NZ oncology centre. Internal Medicine Journal 2012;42:65-70. [DOI: 10.1111/j.1445-5994.2010.02358.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 138 |
Wang HL, Aguilera C, Knopf KB, Chen TB, Maslove DM, Kuschner WG. Thrombocytopenia in the Intensive Care Unit. J Intensive Care Med 2013;28:268-80. [DOI: 10.1177/0885066611431551] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 139 |
Pascoe PJ. Perioperative Management of Fluid Therapy. Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice 2012. [DOI: 10.1016/b978-1-4377-0654-3.00024-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 140 |
Erhabor O, Adias TC. From whole blood to component therapy: the economic, supply/demand need for implementation of component therapy in sub-Saharan Africa. Transfus Clin Biol 2011;18:516-26. [PMID: 22037104 DOI: 10.1016/j.tracli.2011.06.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 141 |
Gilliss BM, Looney MR, Gropper MA. Reducing noninfectious risks of blood transfusion. Anesthesiology 2011;115:635-49. [PMID: 21792054 DOI: 10.1097/ALN.0b013e31822a22d9] [Cited by in Crossref: 112] [Cited by in F6Publishing: 115] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 142 |
Jaime-Pérez JC, Colunga-Pedraza PR, Gómez-Almaguer D. Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? Pediatr Blood Cancer 2011;57:217-23. [PMID: 21671359 DOI: 10.1002/pbc.22957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 143 |
Estcourt LJ, Stanworth SJ, Murphy MF. Platelet transfusions for patients with haematological malignancies: who needs them?: Review. British Journal of Haematology 2011;154:425-40. [DOI: 10.1111/j.1365-2141.2010.08483.x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 4.1] [Reference Citation Analysis]
|
| 144 |
Kwaan HC, Huyck T. Thromboembolic and bleeding complications in acute leukemia. Expert Rev Hematol 2010;3:719-30. [PMID: 21091148 DOI: 10.1586/ehm.10.71] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 145 |
George MR, Herman JH, Holdbrook T, Cui C, Vardhana HG, Behling EM. Platelet refractoriness in acquired hemophagocytic syndrome. Transfusion 2011;51:2319-26. [PMID: 21599673 DOI: 10.1111/j.1537-2995.2011.03182.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
|
| 146 |
Perseghin P. High concentration plasma-reduced plateletapheresis concentrates. Transfus Apher Sci 2011;44:273-6. [PMID: 21507725 DOI: 10.1016/j.transci.2011.03.004] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 147 |
Drozd-sokolowska JE, Wiktor-jedrzejczak W. Factors determining the risk of severe (WHO grades 3 and 4) hemorrhage in hematologic patients. Transfusion and Apheresis Science 2011;44:129-34. [DOI: 10.1016/j.transci.2011.01.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 148 |
Valent J, Schiffer CA. Thrombocytopenia and platelet transfusions in patients with cancer. Cancer Treat Res 2011;157:251-65. [PMID: 21052961 DOI: 10.1007/978-1-4419-7073-2_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 149 |
Apelseth TO, Hervig T, Bruserud O. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia. Blood Rev 2011;25:113-22. [PMID: 21316823 DOI: 10.1016/j.blre.2011.01.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 150 |
Hough BO, Chatta GS. Hematological Changes, Anemia, and Bleeding in Older Persons. Principles and Practice of Geriatric Surgery 2011. [DOI: 10.1007/978-1-4419-6999-6_5] [Reference Citation Analysis]
|
| 151 |
Sayed D, Bakry R, El-sharkawy N, Zahran A, Khalaf MR. Flow cytometric platelet cross-matching to predict platelet transfusion in acute leukemia. J Clin Apheresis 2011;26:23-8. [DOI: 10.1002/jca.20273] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 152 |
Rebulla P. Transfusion Support and Hematopoietic Growth Factors. Leukemias: Principles and Practice of Therapy 2010. [DOI: 10.1002/9781444327359.ch33] [Reference Citation Analysis]
|
| 153 |
Guillaumin J, Jandrey KE, Norris JW, Tablin F. Analysis of a commercial dimethyl-sulfoxide-stabilized frozen canine platelet concentrate by turbidimetric aggregometry: Aggregometry of DMSO frozen platelet concentrate. Journal of Veterinary Emergency and Critical Care 2010;20:571-7. [DOI: 10.1111/j.1476-4431.2010.00580.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 154 |
Buhrkuhl DC. An update on platelet transfusion in hematooncology supportive care. Transfusion 2010;50:2266-76. [PMID: 20492606 DOI: 10.1111/j.1537-2995.2010.02688.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
|
| 155 |
Mcvey M, Cserti-gazdewich CM. Platelet transfusion refractoriness responding preferentially to single donor aphaeresis platelets compatible for both ABO and HLA. Transfusion Medicine 2010;20:346-53. [DOI: 10.1111/j.1365-3148.2010.01011.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 156 |
Maniatis A. From Blood Transfusion to Transfusion Medicine. Alternatives to Blood Transfusion in Transfusion Medicine 2010. [DOI: 10.1002/9781444319583.ch1] [Reference Citation Analysis]
|
| 157 |
van der Meer PF, Tomson B, Brand A. In vivo tracking of transfused platelets for recovery and survival studies: an appraisal of labeling methods. Transfus Apher Sci 2010;42:53-61. [PMID: 19931490 DOI: 10.1016/j.transci.2009.10.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
|
| 158 |
Fuller AJ, Bucklin BA. Blood product replacement for postpartum hemorrhage. Clin Obstet Gynecol 2010;53:196-208. [PMID: 20142656 DOI: 10.1097/GRF.0b013e3181cc42a0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 22] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 159 |
Marktel S, Napolitano S, Zino E, Cappelli B, Chiesa R, Poli F, Crocchiolo R, Ronchi P, Rossini S, Ciceri F, Roncarolo MG, Fleischhauer K. Platelet transfusion refractoriness in highly immunized beta thalassemia children undergoing stem cell transplantation. Pediatr Transplant 2010;14:393-401. [PMID: 20070557 DOI: 10.1111/j.1399-3046.2009.01282.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 160 |
Carlson KS, DeSancho MT. Hematological issues in critically ill patients with cancer. Crit Care Clin 2010;26:107-32. [PMID: 19944278 DOI: 10.1016/j.ccc.2009.09.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 161 |
Villalonga A, Castrillo I, March X. Indicaciones de la transfusión de plaquetas. Tratado de Medicina Transfusional Perioperatoria 2010. [DOI: 10.1016/b978-84-8086-637-8.50020-3] [Reference Citation Analysis]
|
| 162 |
Klein HG. How safe is blood, really? Biologicals 2010;38:100-4. [DOI: 10.1016/j.biologicals.2009.10.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 163 |
Nixon C. Blood Transfusion Therapy. Pediatric Oncology 2010. [DOI: 10.1007/978-3-540-87984-8_31] [Reference Citation Analysis]
|
| 164 |
Thomas L, Kaidomar S, Kerob-bauchet B, Moravie V, Brouste Y, King JP, Schmitt S, Besnier F, Abel S, Mehdaoui H, Plumelle Y, Najioullah F, Fonteau C, Richard P, Césaire R, Cabié A. Prospective observational study of low thresholds for platelet transfusion in adult dengue patients. Transfusion 2009;49:1400-11. [DOI: 10.1111/j.1537-2995.2009.02132.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
|
| 165 |
Peddinghaus ME, Tormey CA. Platelet-Related Bleeding: An Update on Diagnostic Modalities and Therapeutic Options. Clinics in Laboratory Medicine 2009;29:175-91. [DOI: 10.1016/j.cll.2009.03.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 166 |
Depriest KL, Wahla AS, Chatterjee AB, Chin R, Conforti J. Bronchoscopic Myths and Legends. Clinical Pulmonary Medicine 2009;16:172-174. [DOI: 10.1097/cpm.0b013e3181a2c5cd] [Reference Citation Analysis]
|
| 167 |
Guarneri V, Conte P. Acute and subacute toxicities of medical anticancer treatment. European Society of Medical Oncology Handbooks 2009. [DOI: 10.3109/9780203092101.011] [Reference Citation Analysis]
|
| 168 |
Pereira J. Control of Bleeding in Cancer. Cancer Treatment and Research 2009. [DOI: 10.1007/978-0-387-79962-9_18] [Reference Citation Analysis]
|
| 169 |
Searle E, Pavord S, Alfirevic Z. Recombinant factor VIIa and other pro-haemostatic therapies in primary postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol 2008;22:1075-88. [PMID: 18838340 DOI: 10.1016/j.bpobgyn.2008.08.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 170 |
Bündgen N, Gerber B. Supportive Therapie mit Blut und Blutkomponenten. Gynäkologe 2008;41:597-602. [DOI: 10.1007/s00129-008-2171-3] [Reference Citation Analysis]
|
| 171 |
Silliman CC. The transfusion of pre storage leukoreduced packed red blood cells to injured patients. Crit Care Med 2008;36:1661-2. [PMID: 18448929 DOI: 10.1097/CCM.0b013e3181704602] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 172 |
Hess JR. Massive transfusion for trauma: opportunities and risks. ISBT Science Series 2008;3:197-201. [DOI: 10.1111/j.1751-2824.2008.00166.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 173 |
Busani S, Cavazzuti I, Marietta M, Pasetto A, Girardis M. Strategies to Control Massive Abdominal Bleeding. Transplantation Proceedings 2008;40:1212-5. [DOI: 10.1016/j.transproceed.2008.03.119] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 174 |
Christensen RD. Advances and controversies in neonatal ICU platelet transfusion practice. Adv Pediatr 2008;55:255-69. [PMID: 19048733 DOI: 10.1016/j.yapd.2008.07.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 175 |
Blajchman MA, Slichter SJ, Heddle NM, Murphy MF. New Strategies for the Optimal Use of Platelet Transfusions. Hematology 2008;2008:198-204. [DOI: 10.1182/asheducation-2008.1.198] [Cited by in Crossref: 60] [Cited by in F6Publishing: 73] [Article Influence: 4.0] [Reference Citation Analysis]
|
